Your support fuels our research to #EndALS! Donate Now


TDI 142

Scientists at the ALS Therapy Development Institute are conducting research on this small molecule to determine if it can be an effective treatment for ALS by addressing the hyperexcitability of motor neurons of PALS.


Type: Small Molecule
Stage: Preclinical
Status: Active
Sponsor: ALS Therapy Development Institute

TDI Says:

Our team is working to finalize the formulation strategy that will be used throughout the preclinical testing of this compound. 

Comment on this Topic

(All comments are moderated before they appear here.)